VanEck Biotech ETF Rating $245.36 +1.58 (+0.65%) Closing price 04:00 PM EasternExtended Trading$245.28 -0.09 (-0.03%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsShort Interest VanEck Biotech ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.68Holdings in BBH have an aggregate rating of Moderate Buy based on 523 analyst ratings issued in the past year covering 24 companies (99.9% of the portfolio).BBH Aggregate Price Target$245.36High Prediction$245.36Average Prediction$245.36Low Prediction$245.36Holdings in BBH have an aggregate price target of $245.36 and a range of $245.36 to $245.36 covering 24 companies (99.9% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings14.08%AMGNAmgen$414.61+2.1%Hold$383.46 -7.5%303.4498 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision12.89%GILDGilead Sciences$150.93+0.8%Moderate Buy$158.78 5.2%293.895 of 5 starsAnalyst Revision8.37%VRTXVertex Pharmaceuticals$526.19+0.7%Moderate Buy$573.83 9.1%233.4956 of 5 stars6.89%REGNRegeneron Pharmaceuticals$788.04-1.0%Moderate Buy$802.18 1.8%243.6768 of 5 stars6.13%MRNAModerna$198.88+2.1%Hold$76.72 -61.4%241.9698 of 5 starsTrending NewsAnalyst ForecastOptions Volume5.28%NTRANatera$412.56+0.9%Moderate Buy$336.07 -18.5%232.0911 of 5 starsAnalyst ForecastOptions Volume5.17%IQVIQVIA$270.12-1.8%Moderate Buy$248.00 -8.2%172.6829 of 5 starsAnalyst Upgrade5.08%RVMDRevolution Medicines$204.97+2.6%Moderate Buy$230.15 12.3%233.1616 of 5 starsAnalyst ForecastInsider Trade4.67%ARGXargenex$959.49-0.3%Moderate Buy$1,158.61 20.8%244.363 of 5 stars3.30%ILMNIllumina$270.00-1.4%Hold$199.13 -26.3%182.1723 of 5 starsTrending News3.23%BIIBBiogen$227.60+0.5%Moderate Buy$230.14 1.1%322.3523 of 5 starsAnalyst Upgrade3.03%ONCBeOne Medicines$360.85+0.2%Buy$402.71 11.6%173.7874 of 5 starsAnalyst UpgradeGap Up2.87%INSMInsmed$117.83-3.1%Buy$201.87 71.3%253.6537 of 5 starsAnalyst Forecast2.81%ALNYAlnylam Pharmaceuticals$255.96+2.6%Moderate Buy$367.20 43.5%233.7903 of 5 stars2.37%INCYIncyte$123.89-0.4%Moderate Buy$124.05 0.1%252.845 of 5 starsAnalyst Forecast2.30%UTHRUnited Therapeutics$475.45+0.7%Moderate Buy$621.00 30.6%144.4003 of 5 starsTrending NewsAnalyst ForecastInsider Trade1.79%BNTXBioNTech$98.52-0.7%Moderate Buy$126.00 27.9%193.4583 of 5 starsInsider Trade1.71%NBIXNeurocrine Biosciences$138.40-0.4%Moderate Buy$201.09 45.3%244.8316 of 5 starsPositive News1.64%ICLRIcon$172.33-0.9%Hold$170.07 -1.3%172.3701 of 5 stars1.63%CRLCharles River Laboratories International$292.49-0.7%Moderate Buy$287.06 -1.9%162.8002 of 5 starsTrending NewsAnalyst Forecast1.39%TECHBio-Techne$72.61+0.1%Hold$68.92 -5.1%172.8617 of 5 starsPositive News1.36%BMRNBioMarin Pharmaceutical$60.26-1.8%Moderate Buy$89.17 48.0%234.2091 of 5 stars1.03%QGENQiagen$44.15-0.9%Hold$43.51 -1.4%142.5477 of 5 starsNews Coverage0.89%TEMTempus AI$85.01+3.4%Hold$69.63 -18.1%221.6183 of 5 starsTrending NewsInsider Trade This page (NASDAQ:BBH) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
